Conversely, the inhibition of STAT3 activity using STAT3 inhibitors elevates the level of chemoattractant chemokines, including CCL2, CCL9, CCL12, and CCL17, and enhances tumor cell sensitivity to NK-mediated lysis [37]. Here, STAT3 is linked to neoplasm.